Biomarker Lens

Biomarkers · Chemical

KappaLambda Light Chains Free with Ratio

What it measures

Also listed as
Kappa/Lambda Light Chains, Free with Ratio, k, plasma potassium, serum potassium
Unit
Ratio
Tests in the graph that measure it
3

A plain-language description with its source has not been added for this biomarker yet. What the laboratories say about the tests that measure it is below.

Tests that measure KappaLambda Light Chains Free with Ratio

Myeloma Detection Panel Comprehensive

Laboratory
Quest Diagnostics
Test code
38480
Specimen
Serum
Fasting
Required

What the laboratory says this test is for

International Myeloma Working Group (IMWG) recommends multiple component testing as Standard of Care for identification of patient with Multiple Myeloma.

Quest Diagnostics test directory, test code 38480

Myeloma Detection Panel Basic

Laboratory
Quest Diagnostics
Test code
38479
Specimen
Serum
Fasting
Required

What the laboratory says this test is for

International Myeloma Working Group (IMWG) recommends multiple component testing as Standard of Care for identification of patient with Multiple Myeloma.

Quest Diagnostics test directory, test code 38479

KappaLambda Light Chains Free with Ratio

Laboratory
Quest Diagnostics
Test code
11234
Specimen
Serum
Fasting
Not stated as required

What the laboratory says this test is for

The Kappa/Lambda Light Chains, Free with Ratio, Serum test measures the amount of kappa and lambda free light chains (FLCs) in the blood and calculates the kappa to lambda ratio. It is used to assist in the diagnosis of plasma cell disorders, including multiple myeloma, primary amyloidosis, monoclonal gammopathy of unknown significance (MGUS), Waldenstr�m's macroglobulinemia, and related disorders. It is also used to monitor disease activity and treatment.Kappa and lambda light chains link with heavy chains to form immunoglobulins. In healthy individuals, most serum light chains are bound to heavy chains. However, excess plasma-cell proliferation associated with plasma-cell disorders can cause an excess of circulating FLCs and increase or decrease the K/L ratio.This test is intended for patients clinically suspected of having hematologic disease, based on certain symptoms and medical conditions. These include bone pain, bone fractures, normocytic anemia, kidney disease, and recurrent infections suggestive of an underlying plasma-cell disorder.Note that blood samples that are grossly hemolyzed or lipemic or contain high levels of circulating immune complexes (CICs) should not be tested, because of the unpredictable degree of nonspecific scatter these sample types may generate.

Quest Diagnostics test directory, test code 11234

About this page

Everything above is drawn from the named sources and shown as they published it. Reference ranges belong to the laboratory that issued them and the population it named; they are not a universal normal. This page describes the biomarker in general and does not interpret anyone's result. For your own numbers, talk to a clinician, or use Aumnivida, which reads the same graph next to your records.

Found an error? Write to hello@biomarkerlens.com with the page link and the source that contradicts it.